Marna WILLIAMS,J. Yun Tso,Nicholas F. Landolfi,Gao Liu
申请号：
US16599035
公开号：
US20200031929A1
申请日:
2019.10.10
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention is directed to antagonists of CS1 that bind to and neutralize at least one biological activity of CS1. The invention also includes a pharmaceutical composition comprising such antibodies or antigen-binding fragments thereof. The present invention also provides for a method of preventing or treating disease states, including autoimmune disorders and cancer, in a subject in need thereof, comprising administering into said subject an effective amount of such antagonists.
